Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up

Ad

Connect Twitter with Market Wire News

ECYT News and Press Endocyte Inc.


home / stock / ecyt / ecyt news

RSS
ECYT ECYT Quote ECYT Short ECYT News ECYT Articles ECYT Message Board
  • Clovis: Shifting Toward Nuclear Medicine

    Clovis, a "trading stock," has some shakiness in its fundamentals. Moreover, the shares tend to rise and fall for you to trade for short-term gains. Due to upcoming catalysts in June, Clovis is a trading stock that is about to embark on another bullish cycle. Despite being a tradi...

    • April 25, 2022 12:33:52 pm
    • |
    • SeekingAlpha
    • |
      • ECYT Stock
      • ECYT Quote
      • ECYT Short
      • ECYT News
      • ECYT Articles
      • ECYT Message Board
  • Progenics: Why I Finally Decided To Buy

    I have been hesitant about buying into Progenics Pharmaceuticals ( PGNX ) due to my insufficient knowledge about the advancements of radiopharmaceuticals in the oncology arena. Perhaps it is all the hype of immuno-oncology and the rise of gene therapy that caused me to believe that radiopharma...

    • March 18, 2019 06:51:04 pm
    • |
    • SeekingAlpha
    • |
      • ECYT Stock
      • ECYT Quote
      • ECYT Short
      • ECYT News
      • ECYT Articles
      • ECYT Message Board
  • Time To Connect The Dots (Stocks To Watch Podcast)

    Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions, and other key events that could impact stocks. If you are interested in listening to Stocks To Watch to start your Sunday, look ...

    • December 16, 2018 08:04:21 am
    • |
    • SeekingAlpha
    • |
      • ECYT Stock
      • ECYT Quote
      • ECYT Short
      • ECYT News
      • ECYT Articles
      • ECYT Message Board
  • Stocks To Watch: Time To Connect The Dots

    Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. There are two monster meetings on the agenda next week that could shake things up f...

    • December 15, 2018 09:12:29 am
    • |
    • SeekingAlpha
    • |
      • ECYT Stock
      • ECYT Quote
      • ECYT Short
      • ECYT News
      • ECYT Articles
      • ECYT Message Board
  • Endocyte Q3

    Endocyte (NASDAQ: ECYT ) Q3 results ($M): Net loss: (23.3) ( -84.9%). More news on: Endocyte, Inc., Novartis AG, Healthcare stocks news, Earnings news and commentary, Read more ...

    • November 07, 2018 04:07:27 pm
    • |
    • SeekingAlpha
    • |
      • ECYT Stock
      • ECYT Quote
      • ECYT Short
      • ECYT News
      • ECYT Articles
      • ECYT Message Board
  • Endocyte Provides Third Quarter 2018 Financial Results and Operational Update

    Entered into agreement and plan of merger with Novartis AG for $2.1Billion                  WEST LAFAYETTE, Ind., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics...

    • November 07, 2018 04:01:00 pm
    • |
    • GlobeNewswire
    • |
      • ECYT Stock
      • ECYT Quote
      • ECYT Short
      • ECYT News
      • ECYT Articles
      • ECYT Message Board
  • Best Performing Stocks YTD 2018

    There are 66 stocks in the Russell 3,000 that are up more than 100% year-to-date in 2018. Below is a list of the 40 best performers. As shown, three stocks - NII Holdings (NIHD), Tandem Diabetes (TNDM), and Turtle Beach (HEAR) - are up 1,000%+ year-to-date, meaning they've recorded "10-baggers...

    • November 07, 2018 03:12:21 am
    • |
    • SeekingAlpha
    • |
      • ECYT Stock
      • ECYT Quote
      • ECYT Short
      • ECYT News
      • ECYT Articles
      • ECYT Message Board
  • A Migrating Biotech Bear

    Biotech Pulse Biotechnology is in a Bear Market. At least the midcap and smallcap segment of it. The S&P Biotechnology Select Index ( XBI ), which is weighted towards the midcap and smallcap companies, has dropped 24% from its high recorded on August 30 to its lowest point past Monda...

    • November 06, 2018 08:39:35 am
    • |
    • SeekingAlpha
    • |
      • ECYT Stock
      • ECYT Quote
      • ECYT Short
      • ECYT News
      • ECYT Articles
      • ECYT Message Board
  • Endocyte to Present at Two Investor Conferences on October 2nd

    WEST LAFAYETTE, Ind., Sept. 27, 2018 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company developing targeted therapeutics for personalized cancer treatment, today announced that the company’s management team will present at two upcoming investor conferences ...

    • September 27, 2018 08:01:00 am
    • |
    • GlobeNewswire
    • |
      • ECYT Stock
      • ECYT Quote
      • ECYT Short
      • ECYT News
      • ECYT Articles
      • ECYT Message Board
Stock Information

Endocyte Inc. Company Name:

ECYT Stock Symbol:

NASDAQ Market:

Endocyte Inc. Website:

Get ECYT Alerts

News, Short Squeeze, Breakout and More Instantly...

Ad

Connect Twitter with Market Wire News
RECENT ECYT NEWS
  • Research
  • Stock Search
  • News Releases
  • Articles
  • Message Boards
  • Trending Stocks
  • Short Information
  • Stock Wall
  • Coins
  • Link Twitter
  • Sign Up
  • Login
  • Contact

Join us on Discord

Join us on Discord

Follow us on discord to get immediate notifications!

Check out the New Market Wire News Discord Bot

Discord


Sign up or login to continue

Sign up or login to continue.


Forgot password?




Mobile Number Subscribers

Market Wire News provides notifications to customers about updates, service, reminders, or products. Current and new customers of Market Wire News will enter their mobile numbers on a web opt-in form https://marketwirenews.com. Supported Carriers are as follows Alltel, AT&T, Cincinnati Bell, Dobson Cellular Systems, Inter Op, MetroPCS®, Nextel Communications, Sprint PCS, T-Mobile®, U.S. Cellular®, Verizon Wireless, and Virgin Mobile U.S. T-Mobile® is not liable for delayed or undelivered messages. There are no premium charges for joining Market Wire News service. Message and data rates may apply. Subscribers to Market Wire News service may receive up to 500 per month.

How to Opt Out

To opt-out of the Market Wire News program, send or text STOP, END, QUIT, CANCEL or UNSUBSCRIBE to (844) 931-3999. An unsubscribe message will be sent to your number confirming the cancellation, but no more messages will be sent after that one.

Mobile Support

For support or information about a Market Wire News, send or text HELP to (844) 931-3999. Optionally, you may email support@marketwirenews.com.

WATCH LIVE TRENDING STOCKS

Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Log In

Sign Up

Stay Connected

Follow @marketwirenews

| Facebook

| Telegram

| LinkedIn

| Reddit

| Discord


Contact

Privacy

Terms of Service

Disclaimer

© 2023 Market Wire News